|
RAP1GDS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.98409988228354E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.52169992956908E-10 |
| Normal-vs-Stage2 |
1.300370E-03 |
| Normal-vs-Stage3 |
4.22140000000404E-05 |
| Normal-vs-Stage4 |
5.914400E-02 |
| Stage1-vs-Stage2 |
4.548200E-01 |
| Stage1-vs-Stage3 |
8.405000E-01 |
| Stage1-vs-Stage4 |
7.914200E-01 |
| Stage2-vs-Stage3 |
3.855200E-01 |
| Stage2-vs-Stage4 |
7.956800E-01 |
| Stage3-vs-Stage4 |
7.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9748003232678E-10 |
| Normal-vs-AfricanAmerican |
1.516740E-03 |
| Normal-vs-Asian |
4.737800E-03 |
| Caucasian-vs-AfricanAmerican |
1.421220E-01 |
| Caucasian-vs-Asian |
8.443800E-01 |
| AfricanAmerican-vs-Asian |
7.641600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.13848946831286E-12 |
| Normal-vs-Female |
3.747700E-02 |
| Male-vs-Female |
3.175600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.242400E-04 |
| Normal-vs-Extreme_Weight |
1.86659998568928E-09 |
| Normal-vs-Obese |
1.141200E-03 |
| Normal-vs-Extreme_Obese |
2.420800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.813400E-01 |
| Normal_Weight-vs-Obese |
6.633200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.944600E-01 |
| Extreme_Weight-vs-Obese |
1.683410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.750400E-01 |
| Obese-vs-Extreme_Obese |
8.286600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.297400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.32279999953688E-07 |
| Normal-vs-Age(61-80Yrs) |
1.31289999982798E-08 |
| Normal-vs-Age(81-100Yrs) |
6.18359999871032E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.971600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.937000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.255000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.831200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.129020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.623230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.22692999993524E-12 |
| Normal-VS-Type2 PRCC |
4.86560000001468E-06 |
| Normal-VS-KIRP CIMP |
6.734000E-01 |
| Normal-VS-Unclassified PRCC |
2.49419999998057E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.628150E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.575980E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.798230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.091980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.370600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.697800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.78810366092375E-11 |
| Normal-vs-N1 |
5.211700E-04 |
| Normal-vs-N2 |
4.398200E-01 |
| N0-vs-N1 |
1.944240E-01 |
| N0-vs-N2 |
6.683200E-01 |
| N1-vs-N2 |
8.500200E-01 |
|
|
